doi: 10.1172/JCI115251 22
[17] Eli Lilly and Company, 'Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)', ClinicalTrials.gov identifier NCT06260722
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
Supplementation demonstrated the ability to ameliorate inflammation and boost anti-oxidative status, leading to improvements in certain clinical parameters
If you are on multiple medications, there might be concerns or actual interactions that necessitate the discontinuation of one or more drugs, including semaglutide
The aim is to make sure people use FDA-approved drug products, which are reviewed for their safety and how well they work as they move through the supply chain